GGrantIndex
← Search

COVID-19 DEVELOPMENT OF LUNGPACER-PPROTECT, A NEUROSTIMULATION DEVICE TO IMPROVE RESPIRATORY HEALTH AND OUTCOMES FOR MECHANICALLY VENTILATED PATIENTS

$5,355,538FY2021Defense Health AgencyDOD

Lungpacer Medical Usa Inc

Investigators

View source on USAspending →